Logo image of CHSCP

CHS INC - CHSINC 8 PERP (CHSCP) Stock Fundamental Analysis

NASDAQ:CHSCP - Nasdaq - US12542R2094

28.6  -0.05 (-0.17%)

Fundamental Rating

4

Overall CHSCP gets a fundamental rating of 4 out of 10. We evaluated CHSCP against 91 industry peers in the Food Products industry. Both the profitability and the financial health of CHSCP get a neutral evaluation. Nothing too spectacular is happening here. CHSCP does not seem to be growing, but still is valued expensively. CHSCP also has an excellent dividend rating. With these ratings, CHSCP could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CHSCP had a positive cash flow from operations.
CHSCP had positive earnings in each of the past 5 years.
CHSCP had a positive operating cash flow in each of the past 5 years.
CHSCP Yearly Net Income VS EBIT VS OCF VS FCFCHSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

1.2 Ratios

CHSCP's Return On Assets of 7.92% is amongst the best of the industry. CHSCP outperforms 80.23% of its industry peers.
CHSCP's Return On Equity of 14.11% is fine compared to the rest of the industry. CHSCP outperforms 70.93% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.88%, CHSCP is in line with its industry, outperforming 55.81% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHSCP is below the industry average of 9.02%.
The last Return On Invested Capital (5.88%) for CHSCP is above the 3 year average (5.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROIC 5.88%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
CHSCP Yearly ROA, ROE, ROICCHSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 3.62%, CHSCP is in line with its industry, outperforming 51.16% of the companies in the same industry.
In the last couple of years the Profit Margin of CHSCP has grown nicely.
Looking at the Operating Margin, with a value of 2.42%, CHSCP is doing worse than 62.79% of the companies in the same industry.
In the last couple of years the Operating Margin of CHSCP has grown nicely.
CHSCP's Gross Margin of 5.06% is on the low side compared to the rest of the industry. CHSCP is outperformed by 87.21% of its industry peers.
CHSCP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
CHSCP Yearly Profit, Operating, Gross MarginsCHSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 1 2 3 4 5

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCP is destroying value.
The debt/assets ratio for CHSCP has been reduced compared to a year ago.
CHSCP Yearly Shares OutstandingCHSCP Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCP Yearly Total Debt VS Total AssetsCHSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

CHSCP has an Altman-Z score of 2.82. This is not the best score and indicates that CHSCP is in the grey zone with still only limited risk for bankruptcy at the moment.
CHSCP has a better Altman-Z score (2.82) than 66.28% of its industry peers.
The Debt to FCF ratio of CHSCP is 1.02, which is an excellent value as it means it would take CHSCP, only 1.02 years of fcf income to pay off all of its debts.
CHSCP has a Debt to FCF ratio of 1.02. This is amongst the best in the industry. CHSCP outperforms 81.40% of its industry peers.
CHSCP has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
CHSCP has a Debt to Equity ratio of 0.19. This is in the better half of the industry: CHSCP outperforms 63.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Altman-Z 2.82
ROIC/WACC0.99
WACC5.92%
CHSCP Yearly LT Debt VS Equity VS FCFCHSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCP has a Current Ratio of 1.58. This is a normal value and indicates that CHSCP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.58, CHSCP is in line with its industry, outperforming 48.84% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that CHSCP may have some problems paying its short term obligations.
The Quick ratio of CHSCP (0.91) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.91
CHSCP Yearly Current Assets VS Current LiabilitesCHSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

The Revenue for CHSCP has decreased by -17.09% in the past year. This is quite bad
Measured over the past years, CHSCP shows a small growth in Revenue. The Revenue has been growing by 6.88% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCP Yearly Revenue VS EstimatesCHSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B
CHSCP Yearly EPS VS EstimatesCHSCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCP Price Earnings VS Forward Price EarningsCHSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCP is valued cheaper than 93.02% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHSCP is valued cheaper than 95.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.16
EV/EBITDA 0.99
CHSCP Per share dataCHSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1K 2K 3K

4.3 Compensation for Growth

CHSCP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.00%, CHSCP is a good candidate for dividend investing.
CHSCP's Dividend Yield is rather good when compared to the industry average which is at 3.86. CHSCP pays more dividend than 97.67% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, CHSCP pays a better dividend.
Industry RankSector Rank
Dividend Yield 7%

5.2 History

The dividend of CHSCP has a limited annual growth rate of 0.78%.
CHSCP has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCP has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.78%
Div Incr Years0
Div Non Decr Years21
CHSCP Yearly Dividends per shareCHSCP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

11.11% of the earnings are spent on dividend by CHSCP. This is a low number and sustainable payout ratio.
DP11.11%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Yearly Income VS Free CF VS DividendCHSCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B
CHSCP Dividend Payout.CHSCP Dividend Payout, showing the Payout Ratio.CHSCP Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 8 PERP

NASDAQ:CHSCP (1/22/2025, 11:16:35 AM)

28.6

-0.05 (-0.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-08 2025-01-08
Earnings (Next)04-01 2025-04-01
Inst Owners13.8%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap350.92M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield 7%
Yearly Dividend2.04
Dividend Growth(5Y)0.78%
DP11.11%
Div Incr Years0
Div Non Decr Years21
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.16
P/OCF 0.12
P/B 0.03
P/tB 0.03
EV/EBITDA 0.99
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)178.98
FCFY625.81%
OCF(TTM)233.94
OCFY817.96%
SpS3422.59
BVpS877.08
TBVpS877.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROCE 7.68%
ROIC 5.88%
ROICexc 6.17%
ROICexgc 6.17%
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
FCFM 5.23%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
ROICexc(3y)5.96%
ROICexc(5y)4.73%
ROICexgc(3y)6.08%
ROICexgc(5y)4.81%
ROCE(3y)7.21%
ROCE(5y)6.02%
ROICexcg growth 3Y73.02%
ROICexcg growth 5Y27.66%
ROICexc growth 3Y72.21%
ROICexc growth 5Y27.52%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
F-Score6
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Debt/EBITDA 1.33
Cap/Depr 122.19%
Cap/Sales 1.61%
Interest Coverage 250
Cash Conversion 182.9%
Profit Quality 144.65%
Current Ratio 1.58
Quick Ratio 0.91
Altman-Z 2.82
F-Score6
WACC5.92%
ROIC/WACC0.99
Cap/Depr(3y)76.68%
Cap/Depr(5y)79.95%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.13%
Profit Quality(3y)105.8%
Profit Quality(5y)111.96%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.39%
EBIT growth 3Y69.09%
EBIT growth 5Y26.62%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y620.74%
FCF growth 3Y59.62%
FCF growth 5Y30.48%
OCF growth 1Y387.5%
OCF growth 3Y44.56%
OCF growth 5Y25.04%